THE EFFICIENCY OF 48-WEEK TREATMENT WITH LOPINAVIR/RITONAVIR IN COMBINATION WITH LAMIVUDIN IN HIV-1-INFECTED PATIENTS IN THE ROUTINE CLINICAL SETTINGS OF THE RUSSIAN FEDERATION: RESULTS OF A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY (THE SIMPLE STUDY) ArticleOrlova-Morozova E.A., Plotnikova Y.K., Pokrovskaya A.V., Radzikhovskaya M.V., Sizova N.V., Nagimova F.I., Mikhaylov S.P., Wegzyn C.M., Dorr P.K., Potapov A.V., Kruglova A.I.Эпидемиология и инфекционные болезни. Актуальные вопросы. 2018. С. 56-64
